XML 70 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net income $ 14,165 $ 51,792
Adjustments to reconcile net income to net cash used for operating activities:    
Amortization of value of business acquired 22,823  
Amortization and depreciation 3,761 2,649
Amortization of debt issuance costs 16  
Restricted stock and stock option expense 9,671 2,236
Deferred federal income taxes (8,984) 1,964
Amortization of bond premium and discount, net 10,557 5,701
Net realized investment gain 7,216 (40,226)
Equity in the earnings of a partnership (1,448)  
Changes in:    
Premiums receivable, net 18,971 (12,323)
Reinsurance receivables, net 5,373 19,694
Funds held by ceding insurers 661 (5,100)
Unpaid losses and loss adjustment expenses (35,452) (39,535)
Unearned premiums 4,608 11,169
Ceded balances payable (11,909) (1,027)
Other assets and liabilities, net (13,199) 317
Contingent commissions (2,909) (166)
Federal income tax receivable/payable (2,048) (28)
Deferred acquisition costs, net (32,160) (3,913)
Prepaid reinsurance premiums 9,081 (265)
Net cash used for operating activities (1,206) (7,061)
Cash flows from investing activities:    
Cash release from escrow for business acquisition 113,696  
Acquisition of business, net of cash acquired (92,336)  
Proceeds from sale of fixed maturities 290,580 350,179
Proceeds from sale of equity securities 34,161 181,203
Proceeds from sale of preferred stock 1,540  
Proceeds from maturity of fixed maturities 146,870 66,281
Proceeds from limited partnership distribution 4,287  
Proceeds from other invested assets   12
Amounts paid in connection with derivatives (7,072) (13,182)
Purchases of fixed maturities (485,153) (525,935)
Purchases of equity securities (32,434) (34,033)
Purchases of other invested assets (2,250) (18,475)
Net cash provided by (used for) investing activities (28,111) 6,050
Cash flows from financing activities:    
Net borrowings (repayments) under margin borrowing facilities 21,114 (37,726)
Proceeds from issuance of subordinated notes 100,000  
Debt issuance cost (3,659)  
Tax benefit on share-based compensation expense 58  
Purchase of A ordinary shares (333) (139)
Net cash provided by (used for) financing activities 117,180 (37,865)
Net change in cash and cash equivalents 87,863 (38,876)
Cash and cash equivalents at beginning of period 58,823 105,492
Cash and cash equivalents at end of period $ 146,686 $ 66,616